PHARMACOTHERAPY OF BRONCHIAL ASTHMA: CURRENT STATUS AND PROSPECTS FOR DEVELOPMENT


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

The article discusses modern ideas about the treatment of bronchial asthma, one of the most widespread and socially significant diseases in the world. The issues of treatment of the disease at various stages of therapy and long-term management of patients are considered. The main groups of drugs recommended at present for the management of patients with bronchial asthma with its stable course are presented. The near-term prospects of improving the pharmacotherapy of this disease are discussed.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

A. Emelyanov

North-Western State Medical University n.a. I.I. Mechnikov

Email: aleksandr.emelyanov@szgmu.ru
MD, Prof., Head of the Department of Pulmonology

G. Sergeeva

North-Western State Medical University n.a. I.I. Mechnikov

E. Leshenkova

North-Western State Medical University n.a. I.I. Mechnikov

M. Partavi

North-Western State Medical University n.a. I.I. Mechnikov

Әдебиет тізімі

  1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir. Med. 2017;5:691-706.
  2. Global Strategy for Asthma Management and Prevention. Revised 2018. https://www.ginasthma.org.
  3. Бронхиальная астма. Клинические рекомендации Российского респираторного общества, 2016 г http://www.pulmonology.ru (дата обращения: 14.07.2018).
  4. Chung K., Wenzel S., Brozek J., et al. international ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. 2014;43:343-73
  5. Федосеев Г.Б., Трофимов В.И., Петрова М.А. Многоликая бронхиальная астма, диагностика, лечение и профилактика. СПб., 2011. 344 с
  6. Принципы выбора терапии для больных легкой бронхиальной астмой. Согласованные рекомендации РААКИ и РРО. Практическая пульмонология. 2017;1:82-90
  7. Irwin R.S., Richardson N.D. Side effects with inhaled corticosteroids. Chest. 2006;130([1]Suppl.): 41-53.
  8. Lacasse Y., Archibald H., Ernst P., Boulet L.P. Pattern and determinants of compliance with inhaled steroids in adults with asthma. Can. Respir. J. 2005;12(4):211-17.
  9. Papi A., Canonica G.W., Maestrelli P., et al. BEST Study Group. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N. Engl. J. Med. 2007;356(20):2040-52.
  10. O'Byrne P.M., FitzGerald J.M., Bateman E.D., et al. inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N. Engl. J. Med. 2018;378(20):1865-76.
  11. Bateman E.D., Reddel H.K., O'Byrne P.M., et al. As-Needed Budesonide-Formoterol versus maintenance Budesonide in Mild asthma. N. Engl. J. Med. 2018;378(20):1877-87.
  12. Bousquet J., van Cauwenberge P., Khaltaev N., et al. Allergic rhinitis and its impact on asthma (ARiA)// ARiA. At a glance pocket reference, 1st edition. 2007. 6 p.
  13. Согласованные рекомендации по применению антихолинергического препарата длительного действия тиотропия в терапии бронхиальной астмы. Пульмонология 2015;25(2):143-50.
  14. McCracken J., Tripple J., Calhoun W. Biologic therapy in the management of asthma. Curr. Opin. Allergy Clin. immumol. 2016;16(4):375-82.
  15. Pelaia C., Vatrella A., Bruni A., et al. Benralizumab in the treatment of severe asthma: design, development and potential place in therapy. Drug design, development and therapy 2018;12:619-28.
  16. Lugogo N., Domingo C., Chanez P., et al. Longterm efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a multicenter, open-label, phase lllb study. Clin. Ther. 2016;38(9):2058-70.
  17. Тяжелая бронхиальная астма. Клинические рекомендации Ассоциации русскоговорящих специалистов в области респираторной медицины. М., 2018
  18. Bousquet J., Brusselle G, Buhl R., et al. Care pathways for the selection of a biologic in severe asthma. Eur. Respir. J. 2017;50:1701782.
  19. Castro M., Corren J., Pavord I.D., et al. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N. Engl. J. Med. 2018;378:2486-96.
  20. Rabe K.F., Nair P., Brusselle G., et al. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma. N. Engl. J. Med. 2018;378: 2475-85.
  21. Corren J., Parnes J.R., Wang L., et al. Tezepelumab in Adults with Uncontrolled Asthma. N. Engl. J. Med. 2017;377:936-46.
  22. Gibson P.G., Yang I.A., Upham J.W., et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;12390(10095):659-68.
  23. Torrego A., Sol I., Munoz A.M., et al. Bronchial thermoplasty for moderate or severe persistent asthma in adults. Cochrane Database Syst. Rev. 2014;(3):CD009910.
  24. Wang L., Yin J., Fadel R., et al. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma. Allergy. 2014;9:1181-89.
  25. Virchow C., Backer V., Kuna P., et al. Efficacy of house dust mite allergen sublingual immunotherapy tablets in adults patients with allergic asthma. A randomized clinical trial. JAMA. 2016;315(16):1715-25.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>